Stockreport

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com
PDF Conference call and webcast at 8:00 a.m. Eastern Time todayNEW YORK, April 9, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer [Read more]